Sign Up to like & get
recommendations!
0
Published in 2018 at "Diabetes"
DOI: 10.2337/db18-1076-p
Abstract: Background: Injectable therapy is required when patients with type 2 diabetes (T2D) do not achieve glycemic control despite previous dietary and lifestyle modifications combined with oral antidiabetic therapy. While both Glucagon-like peptide-1 receptor agonists (GLP-1-RA)…
read more here.
Keywords:
clinical measures;
insulin;
glp;
injectable therapy ... See more keywords